bpc-157 human safety data The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity What Science ACTUALLY Says About

We invite researchers to share findings or explore related BPC-157 studies

At 48 weeks, mean percentage changes in body weight from baseline were approximately: In the 12 mg arm, roughly 100% of participants achieved at least 5% body-weight loss, about 83% reached 15% loss, around 63% achieved 20% loss, and approximately 26% crossed the 25% threshold

After 8 weeks, you see minimal improvement and conclude the peptide does not work

Some evidence for modest fat oxidation improvements exists, but human weight loss trials show inconsistent and largely non-significant results for body weight reduction

It also helps to metabolize fats and produce red blood cells and hormones from the adrenal gland

As a result, you are more likely to achieve stable and improved outcomes